SciELO - Scientific Electronic Library Online

 
vol.7 número4Prevalencia de alteraciones del medio interno en pacientes adultos hospitalizados índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Bookmark


Revista Medica Herediana

versión impresa ISSN 1018-130X

Resumen

JAYAWEERA, Dushyantha T; SCERPELLA, Ernesto G; RODRIGUEZ, Allan E  y  FISCHL, Margaret A. Danazol therapy in thrombocytopenia associated with HIV-1 infection. Rev Med Hered [online]. 1996, vol.7, n.4, pp. 150-153. ISSN 1018-130X.

Objective: To evaluate the efficacy of danazol for the treatment of thrombocytopenia associated with human immunodeficiency virus tipe 1 (HIV-1) infection. Patients and Methods: Retrospective, case series study. Eight patients with thrombocytopenia associated with HIV-1 infection, and treated with danazol 300 mg to 800 mg a day for more than 3 months were identified. Follow-up ranged from 3 months to 2 years. Response to treatment was defined as a 25% increase in platelet count from pre-treatment values. Results: The mean platelet count before danazol therapy. Mean platelet counts and standard deviations at 12 and 24 months of therapy were 104± 108 x 109/L (range, 19-88 x 109/L). Seven (87%) of 8 patients responsed to danazol therapy. Mean platelet counts and standard deviations al 12 and 24 months of therapy were 104± 108 x 109/L, and 112± 28 x 109/L. There was a trend towards an increase in platelet counts during treatment. Conclusion: Danazol may be effective in HIV-1 induced trombocytopenia. (Rev Med Hered 1996; 7: 150-153).

Palabras llave : Thrombocytopenia; Danazol; AIDS; HIV.

        · resumen en Español     · texto en Español     · pdf en Español